Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.Diagnosoft, a provider of magnetic resonance image analysis software, has closed $4 million in series B financing led by Technology Development Fund of Cairo, Egypt. The company intends to use the new capital to support further market expansion of Diagnosoft Harp, Diagnosoft Plus, and Diagnosoft Senc.
Subscribe to our email newsletter
The capital infusion will also serve to further the development of other innovative magnetic resonance image analysis technologies designed to increase physician productivity and accuracy, improve patient outcomes, and enhance research and drug development advances.
To continue Diagnosoft’s commitment to cardiovascular imaging advances, the company’s board of directors has appointed Firas BenAchour as president and CEO of Diagnosoft and a member of the board.
Mr BenAchour said: I am delighted to be appointed president and CEO of Diagnosoft, and I am very excited about the opportunities and the growth potential of our company. Since joining Diagnosoft, my principal focus has been to establish our growth strategy for the benefit of our clients, employees and investors.
We are currently focusing on organizing our client services efforts, establishing our sales and business development processes, solidifying our brand and continuing to make improvement to the quality, usability and reliability of our software solutions.